Calamos Wealth Management’s CVS Health CVS Stock Holding History

Calamos Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$806K	Buy	7,787 +256	+3%	+$22.9K	0.02%	246
2026 Q1	$541K	Sell	7,531 -991	-12%	-$76.3K	0.02%	289
2025 Q4	$676K	Buy	8,522 +1,992	+31%	+$157K	0.02%	239
2025 Q3	$492K	Buy	6,530 +1,832	+39%	+$126K	0.02%	269
2025 Q2	$324K	Buy	+4,698	New	+$308K	0.01%	279
2023 Q1	–	Sell	-2,738	Closed	-$255K	–	316
2022 Q4	$255K	Sell	2,738 -21	-0.8%	-$2.03K	0.02%	278
2022 Q3	$263K	Buy	2,759 +388	+16%	+$38.4K	0.02%	268
2022 Q2	$220K	Sell	2,371 -42	-2%	-$4.1K	0.02%	294
2022 Q1	$244K	Buy	+2,413	New	+$253K	0.02%	302
2016 Q4	–	Sell	-2,317	Closed	-$206K	–	226
2016 Q3	$206K	Buy	+2,317	New	+$219K	0.04%	190

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Calamos Wealth Management's CVS Position: Q2 2026 in Review

Calamos Wealth Management increased its CVS Health (CVS) stake by 3.4% in Q2 2026, buying an estimated $22.9K and bringing the position to 7,787 shares worth $806K. The position accounts for 0.02% of the portfolio, ranked #246.

Calamos Wealth Management first reported a position in CVS in Q3 2016 and has held it in 10 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Calamos Wealth Management held 7,787 shares of CVS Health worth $806K as of Q2 2026.
Calamos Wealth Management bought 256 CVS Health shares in Q2 2026, an estimated $22.9K.
CVS Health made up 0.02% of Calamos Wealth Management's portfolio in Q2 2026, its #246 holding.
Calamos Wealth Management first reported a position in CVS Health in Q3 2016 and has held it in 10 quarters since.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Calamos Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.